APA (7th ed.) Citation

Seyyed Majid Eslami, Shekoufeh Nikfar, Maryam Ghasemi, & Mohammad Abdollahi. (2017). Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Seyyed Majid Eslami, Shekoufeh Nikfar, Maryam Ghasemi, and Mohammad Abdollahi. Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials. Frontiers Media S.A., 2017.

MLA (9th ed.) Citation

Seyyed Majid Eslami, et al. Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials. Frontiers Media S.A., 2017.